retatrutide weight loss clinical trial Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced. In The retatrutide drug is manufactured
Description
And it's tricky because some insurances will have certain restrictions on medications
Telehealth platforms have expanded access to compounded alternatives
In both cases, patients face a higher administrative burden and the potential for longer wait times to access their meds
It is mainly found in indigenous to Europe, western Asia, and North America
